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Plasma membrane accumulationCationic antimicrobial peptides (CAMPs) selectively target bacterialmembranesbyelectrostatic interactionswith
negatively charged lipids. It turned out that for inhibition of microbial growth a high CAMP membrane
concentration is required, which can be realized by the incorporation of hydrophobic groupswithin the peptide.
Increasing hydrophobicity, however, reduces the CAMP selectivity for bacterial over eukaryotic hostmembranes,
thereby causing the risk of detrimental side-effects. In this study we addressed how cationic amphipathic
peptides—in particular a CAMP with Lysine–Leucine–Lysine repeats (termed KLK)—affect the localization and
dynamics of molecules in eukaryotic membranes. We found KLK to selectively inhibit the endocytosis of a
subgroup of membrane proteins and lipids by electrostatically interacting with negatively charged sialic acid
moieties. Ultrastructural characterization revealed the formationofmembrane invaginations representingﬁssion
or fusion intermediates, in which the sialylated proteins and lipids were immobilized. Experiments on
structurally different cationic amphipathic peptides (KLK, 6-MO-LF11-322 and NK14-2) indicated a cooperation
of electrostatic and hydrophobic forces that selectively arrest sialylated membrane constituents.y of Applied Science, School of
aße 23, A-4600 Wels, Austria.
ghuber),
-NC-ND license.© 2011 Elsevier B.V.  Open access under CC BY-NC-ND license.1. Introduction
Over the last 30 years antimicrobial peptide research led to the
discovery of more than thousand natural and synthetic substances [1],
whichwere described as being suitable to kill or slowdown the growth
of pathogens [2,3]. Cationic antimicrobial peptides (CAMPs) were
found to be key components of the innate immune response, where
they play a crucial role in host defense against microbial infection.
They are generated by different species including insects, plants,
amphibians, prokaryotes and mammals [4–8]. In mammals, four
groups of CAMPs have been characterized:α-, ß-, and θ-defensins, and
cathelicidins [9–11]. CAMPs kill bacteria very rapidly and thus could
play an important role in ﬁghting the uprising microbial resistance to
conventional antibiotics [12]. Therefore, great effort has been put into
the production of artiﬁcial peptides based on key domains of theirnatural precursors [13] involving also the development of combina-
torial libraries and high-throughput screening technologies [14].
Most CAMPs selectively target bacterial membranes due to the
presence of negatively-charged lipids, while eukaryotic host cells
carrying lipids with no net charge in the outer leaﬂet remain rather
unaffected [15–17]. However, some CAMPs were also shown to act on
intracellular targets, such as DNA or ribosomes [18,19] and multiple
functions for CAMPs especially expressed in higher organisms like
chemotaxis of immune cells, control of the inﬂammatory response or
promoting re-epthelialization and wound closure was reported [19–
22]. For our study we selected the CAMP KLK (KLKL5KLK) derived
from a core undecapeptide of sapecin B, which is effective against
Gram-positive and -negative bacteria as well as fungi with a MIC N
1 μM [23]. Although KLK has been reported to have a profound
membrane interacting property [24], it shows further effects: KLK
activates human neutrophils [25,26], exhibits chemotherapeutic
activity [27], is a potent inducer of adaptive immunity to co-injected
antigens [28] and leads to a fast increase of intracellular calcium levels
[29]. Interestingly, KLK exerts its effect without being taken up by the
cells [30]. The combination of a single stranded oligodeoxynucleotide
(ODN1a) and KLK results in a potent immunostimulatory adjuvant
termed IC31™ [31].
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range of 1 to 10 μΜ [32,33], however, demand for rather high CAMP
concentrations in therapeutic applications. Also studies on model
phospholipid bilayers have indicated that most CAMPs function only
at high membrane-bound concentrations close to full membrane
coverage [34]. In this study, we were interested to which extent
eukaryotic host cells are affected by such high CAMP concentrations.
Indeed, CAMPs are known to interact not onlywith pathogens, but can
also be harmful to mammalian cells. One reason for this may be the
hydrophobicity of some peptides, which decreases the selectivity
between bacterial and host cell membranes [35–37]. We speculated
that the membrane localization of CAMPs containing hydrophobic
regions might enable and stabilize their interaction with negatively
charged protein modiﬁcations present on the eukaryotic cell surface.
Here, we found that application of KLK and other CAMPs led to the
accumulation of sialylated proteins and lipids at the plasmamembrane
of various mammalian cells. The effect was dependent on the presence
of hydrophobic peptide moieties, which enables and stabilizes the
electrostatic interactions between the CAMP and the negatively charged
glycosylations. Ultrastructural investigation revealed the formation of
plasma membrane invaginations upon KLK treatment, indicating that
KLK immobilizes and arrests speciﬁc plasmamembrane constituents by
blocking the ﬁssion or fusion of their carriers.
2. Materials and methods
2.1. Reagents
KLKLLLLLKLK (KLK) and KLKLLPLLKLK (KPK) were provided by
Intercell AG (Vienna, Austria). Hank's buffered salt solution (HBSS;
137 mM NaCl, 5.4 mM KCl, 0.25 mM Na2 HPO4, 0.44 mM KH2PO4,
1.3 mM CaCl2, 1 mM MgSO4, 4.2 mM NaHCO3) and phosphate
buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4,
1.46 mM KH2PO4) were from PAA Laboratories (Pasching, Austria).
Trypan Blue and neuraminidase were purchased from Sigma
Aldrich (Schnellendorf, Germany). Alexa647 labeled Cholera toxin
B, DiD and Bodipy-GM1 were from Invitrogen (Lofer, Austria). The
antimicrobial peptides LF11-322 (PFWRIRIRR-NH2), 6-MO-LF11-
322 (6-methyloctanoyl-LF11-322), NK14 (KILRGVSKKIMRTF-NH2),
and NK14-2 (KILRGVSKKIMRTFKILRGVSKKIMRTF-NH2) were syn-
thesized in their amidated form by PolyPeptide Laboratories San
Diego (CA, USA).
2.2. DNA constructs
The pCR3-GPI-DAF-GFP and pCR3-GPI-TRAIL-GFP plasmids were
provided by Daniel Legler (University of Konstanz, Switzerland), the
pJB20-GPI-hFR-mGFP, GPI-glycan-YFP (GPI-GL-YFP) and CD59-GFP
constructs [38] were a gift by Jennifer Lippincott-Schwartz (NIH,
Bethesda, USA). pEYFP-N1-CD43, pEGFP-N1-Lck, pEYFP-N1-Fyn,
pEYFP-N1-CD3ζ and pEYFP-N1-CD147 were provided by Hannes
Stockinger (Medical University Vienna, Austria), pEGFP-N1-CD71 and
pEGFP-C1-CD63byKatharina Strub (University of Geneva, Switzerland)
and Flotillin-1-GFP and Flotillin-2-GFP by Lawrence Rajendran (ETH
Zurich, Switzerland). The pEGFP-C1-CLCA1 plasmid encoding Clathrin
Light Chain A1 was a gift by Eileen M. Lafer (UTHSC San Antonio, Texas,
USA). The pEGFP-N1-Cav1 (encoding Caveolin-1-GFP) and pEGFP-N1-
Dyn-2 (encoding Dynamin-2-GFP) constructs were provided by Mark
McNiven (Mayo Clinic, Minnesota, USA) and the pcDNA3 4+ and 8+−
GFP plasmids were a gift by John Silvius (McGill University, Montreal,
Canada). The pEGFP-N1-Orai1 and pEYFP-N1-(PH)δ constructs were
from Christoph Romanin. We further obtained pSRα(puro) CD43-45-
YFP and pSRα(puro) Thy-1-CD45 plasmids from the lab of Anton van
derMerwe (OxfordUniversity, Oxford,UK). ThepEGFP-C1-Lact-C2 (GFP
fused with C2 domain of bovine Lactadherin) was purchased fromHaematologic Technologies Inc., Essex Junction, Vermont, USA). The
pEGFP-N1-Orai1 construct has been described previously [39].2.3. Cell culture
Human T24, HeLa, CHO-K1 cells were from American Type Culture
Collection Media, and HEK293 cells were provided by Christoph
Romanin (JKU Linz, Austria). CHO-K1 cell stably expressing SR-BI-
EGFP were a gift by Herbert Stangl (Medical University Vienna,
Austria). Fetal bovine serum (FBS), media, antibiotics, trypsin and
Geneticin (G418 sulphate) were purchased from PAA Laboratories
GmbH, (Pasching, Austria). Culture plates were from Greiner Bio One
International (Kremsmuenster, Austria). A Gene Pulser electropora-
tion unit (X-cell) and electroporation cuvettes were from Bio-Rad (CA,
USA).
T24 and HeLa cells were cultured in RPMI medium supplemented
with 10% FBS and grown at 37 °C in a humidiﬁed incubator (≥95%)
with 5% CO2. For stable expression 70% conﬂuent cells were harvested
and transfected with 10 μg plasmid DNA using the X-Cell electro-
porator with following electroporation conditions: 240 V, 950 μF,
unlimited resistance, 4 mm gap cuvettes and RPMI16 without FBS as
the electroporation-buffer. Cells were plated into 100 mm culture
dishes and grown for 48 h. The medium was removed and replaced
with fresh medium supplemented with 400 μg/ml G418. Mediumwas
changed every 3 days, and 15–20 days later individual neomycin-
resistant colonies were selected for propagation and analysis. CHO-K1
cells were cultured in DMEM High Glucose medium supplemented
with 5% FBS; the same medium supplemented with 10% FBS was used
to culture HEK293 cells. Transfection was performed with the X-Cell
electroporator following preset protocols according to the manufac-
turer. Stable clones were established using the same procedure as for
T24 cells. For transient expression the same transfection protocols
were used. Transfected cells were grown on 3 cm glass coverslips and
analyzed 48 h after seeding.
For the preparation of human immature dendritic cells whole
human heparinized blood was obtained from the Red Cross and
500 ml of blood was diluted 1:1 in PBS. Diluted blood was placed on
LSM 1077 lymphocyte separation medium (PAA, Pasching, Austria)
gradient and centrifuged for 20 min at 350 g. Monocytes were
harvested and CD14+ cells were selected by MACS puriﬁcation
(Miltenyi Biotec, Bergisch Gladbach, Germany) and incubated in RPMI
1640 supplemented with 10% Fetal bovine serum (PAA, Pasching,
Austria), 1% L-glutamine, 1% Sodium-Pyruvate, 0.1% β-mercaptoetha-
nol, 500 U/ml IL-4 and 0.1 μg/ml GM-CSF at 37 °C in 5% CO2 for 7 days.
At day 6 of culture, CD83 (below 10%), CD1a (50–70%) andMHCII (70-
90%) were assured by FACS analysis. At day 7 non-adherent cells were
collected and used in subsequent experiments.2.4. Fluorescence microscopy and image analysis
The detection system was set up on a home-made ultra-sensitive
biochip scanner described in detail elsewhere [40,41]. The device is
based on an epi-ﬂuorescence microscope (Axiovert 200/M, Zeiss,
Germany). Ar+- and Kr+-ion lasers (Innova, Coherent, USA) were
used for selective ﬂuorescence excitation of GFP, YFP and Cy5 at
488 nm, 514 nm and 647 nm, respectively. Samples were illuminated
in objective-type total internal reﬂection (TIR) conﬁguration using a
100× oil immersion objective (NA=1.45, α-Fluar, Zeiss, Germany).
After appropriate ﬁltering using standard ﬁlter sets (Chroma
Technology Corp., VT, USA), ﬂuorescence was imaged onto a back-
illuminated CCD camera (NTE/CCD-1340/100-EMB, Roper Scientiﬁc,
USA). LSM images were taken by means of a LSM 510 Meta confocal
laser scanning microscope using a 40×1.2NA water immersion
objective (Zeiss, Germany). Formicroscopy, cells were placed in HBSS.
Fig. 1. KLK induces the accumulation of GPI-anchored proteins along the plasma
membrane. T24 cells expressing GPI-hFR-mGFP were seeded on glass slides and
analyzed by TIRF microscopy in the absence or presence of 100 μM KLK (A) or a mutant
variant of KLK, termed KPK (B). (C) Two-color ﬂuorescence microscopy experiments of
the same cells additionally labeled with the ﬂuorescent lipid tracer DiD. The incubation
time of KLK or KPK was 5 min. Scale bars 20 μm (A), 25 μm (B), 10 μm (C).
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FRAP experiments were performed at 37 °C on a setup described in
detail previously [42]. A Zeiss Axiovert 200 microscope was equipped
with a 100×NA=1.45 Plan-Apo objective (Olympus). Samples were
illuminated in objective-type TIR conﬁguration via the epiport using
488 nm (GFP excitation) from an Ar+ Laser (Model 2020, Spectra
Physics). A slit diaphragmwith a width of 7 μmwas used as ﬁeld stop
to conﬁne the illumination area. Images were recorded using a back-
illuminated liquid nitrogen cooled CCD camera (Micro Max 1300-PB,
Roper Scientiﬁc). Images were photobleached with a laser pulse
applied for 650 ms; the recovery image was recorded at an
illumination time of 1 ms, 30 s after the photobleaching pulse. A
pre-bleach image was recorded with an illumination time of 1 ms
before the photobleaching pulse in order to calculate the mobile
fraction of the ﬂuorescent probe.
2.6. Fluorescent labeling, quenching and neuraminidase treatment
For DiD or Bodipy-GM1 labeling, cells were grown on glass
coverslips for 16 h and incubated with loading solution: 1 μM Bodipy-
GM1 in HBSS for 30 min at 4 °C or 5 μl of the DiD labeling solution
supplied by the manufacturer in 1 ml HBSS for 15 min at 37 °C was
added. After loading, cells were rinsed with HBSS buffer for three
times and immediately used for further experiments. For ﬂuorescence
quenching experiments cells grown on glass coverslips were washed
with HBSS buffer and incubated with 0.2% Trypan Blue in HBSS for
2 min. Cells were washed three times with HBSS buffer before
performing further experiment. Cleavage of sialic acid residues was
achieved by incubation of cells grown on glass cover slips with 1 U/ml
neuraminidase in HBSS buffer for 1 h at 37 °C.
2.7. Electron microscopy
T24 cells were grown on Aclar plastics to a cell density of 80% and
incubated with 10 μM KLK dissolved in medium for 5 min. Control
samples without KLK were treated under the same conditions. For
antibody staining samples were incubated with an anti-GFP-antibody
(Ab290; 1:1000; in blocking serum) for 1 h followed by washing for 3
times in blocking serum. An anti-rabbit HRP linked antibody in
blocking serum was administered for 1 h. Microwave ﬁxation and
processing of cell monolayers for transmission electron microscopy
was described in detail elsewhere [43]. Cells on Aclar were
microwave-ﬁxed in 0.5% glutaraldehyde in 0.15 M Sorensen's buffer,
pH 7.4 for 15 s, followed by immersion in 3% glutaraldehyde for
30 min. For subsequent processing, including washing, postﬁxation in
1% OsO4, dehydration in ethanol, and inﬁltration with epoxy resin
(Agar 100, Agar Scientiﬁc; Cambridge, UK), a tissue processor was
used (LEICA TP, Microsystems, Vienna, Austria). After polymerization
the resin block was separated from the Aclar plastics. Thin sections
(60–80 nm) were cut with an ultramicrotome Ultracut S (LEICA
Microsystems), mounted on copper grids, stained with uranyl acetate
and lead citrate, and examined at 80 kV in a JEM-1210 electron
microscope (JEOL; Tokyo, Japan). Images were acquired using a digital
camera (Morada; Soft Imaging System GmbH, Münster, Germany)
and analySIS FIVE software.
2.8. Cytotoxicity assays
The Resazurin-based cytotoxicity assay (Sigma Aldrich, Schnel-
lendorf, Germany) was performed according to the instructions of the
manufacturer. Brieﬂy, cells were seeded in 96-well plates and treated
by KLK or KPK diluted in HBSS buffer for 15 min at room temperature.
Subsequently, the cells were incubated with medium containing 10%
Resazurin for 2 h. The reduced form of Resazurin (Resoruﬁn) was then
detected by a ﬂuorescence microplate reader (Polarstar, BMGLabtech). The viability of KLK or KPK treated cells was normalized to
the one of non-treated cells grown under the same conditions.
3. Results
3.1. KLK leads to accumulation of GPI-anchored proteins along the plasma
membrane
To test for an effect of KLK on glycosylated membrane proteins, we
ﬁrst studied the plasma membrane localization of GPI-anchored
proteins in the human bladder carcinoma cell line T24. Fluorescence
microscopy was performed under Total Internal Reﬂection (TIR)
excitation to reduce cytosolic background ﬂuorescence. Addition of
100 μMKLK led to a fast redistribution of monomeric GFP fused to the
GPI-anchor of the human folate receptor (GPI-hFR-mGFP), resulting in
the enrichment of this protein along the plasma membrane (Fig. 1A;
Supplementary Movie 1). Similar results were obtained using the GPI-
anchor of the decay accelerating factor (DAF or CD55; here termed
GPI-DAF-GFP), of the TRAIL-receptor 3 (GPI-TRAIL-GFP), and of the
GPI-anchored protein CD59-GFP (data not shown; see Table 1). The
effect was also observed at tenfold lower concentrations of KLK (data
not shown), but not with an immunologically inert derivative of KLK
(KLKLLPLLKLK, KPK) [24] at 100 μM (Fig. 1B). Interestingly, we were
not able to compete the effect of 100 μM KLK by simultaneous
application of 1 mM KPK (Supplementary Fig. 1). Unless stated
100 μM peptide concentrations were used in all further experiments.
Cells remained their viability under these circumstances (Supple-
mentary Fig. 2).
To control for a putative general effect of KLK on the distribution of
plasma membrane constituents, we uniformly labeled the plasma
membrane of GPI-hFR-mGFP-expressing T24 cells with the
Table 1
List of all molecules which have been tested for sensitivity to KLK within this study, and
their respective membrane localization.
Molecules affected
by KLK
KLK effect Membrane localization
GPI-hFR-mGFP accumulation in plasma
membrane
outer leaﬂet inserted
GPI-Trail-GFP accumulation in plasma
membrane
outer leaﬂet inserted
GPI-DAF-GFP accumulation in plasma
membrane
outer leaﬂet inserted
GPI-CD58-GFP accumulation in plasma
membrane
outer leaﬂet inserted
CD59-GFP accumulation in plasma
membrane
outer leaﬂet inserted
Cholera Toxin B accumulation in plasma
membrane
bound to GM1 in outer leaﬂet
Bodipy-GM1 accumulation in plasma
membrane
outer leaﬂet inserted
CD43-YFP accumulation in plasma
membrane
single-pass type I membrane
protein
CD63-GFP accumulation in plasma
membrane
multi-passmembrane protein
4+−GFP cell rupture inner leaﬂet associated
8+−GFP cell rupture inner leaﬂet associated
PH-YFP cell rupture inner leaﬂet associated
Molecules not affected
by KLK
KLK effect Membrane localization
Caveolin-1-GFP none inner leaﬂet inserted
Lck-GFP none inner leaﬂet inserted
Fyn-YFP none inner leaﬂet inserted
Flottilin1-GFP none peripheral inner leaﬂet
Flottilin2-GFP none peripheral inner leaﬂet
CD71-GFP none single-pass type II
membrane protein
Orai1-GFP none multi-passmembrane protein
CD147-YFP none single-pass type I membrane
protein
SRBI-GFP none multi-passmembrane protein
SRBII-GFP none multi-passmembrane protein
CD3ζ-GFP none single-pass type I membrane
protein
Clathrin light
chain-GFP
none peripheral inner leaﬂet
DiD none plasma-membrane
integrated
Fig. 2. The effect of KLK on the localization of GPI-anchored proteins is not restricted to
a certain cell line. CHO-K1 (A), HEK293 (B) and HeLa (C) cells expressing GPI-hFR-
mGFP were analyzed by TIRF microscopy in the absence or the presence of 100 μM KLK
(5 min incubation time). Scale bars 15 μm (A), 20 μm (B) and 10 μm (C).
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experiments revealed the accumulation of GPI-hFR-GFP upon KLK
treatment as described above, while the distribution of DiD remained
unaffected (Fig. 1C). In order to analyze the effects of KLK in different
cell lines, we expressed GPI-hFR-mGFP in CHO-K1, HEK293 and HeLa
cells and treated them with KLK. We found similar accumulation of
GPI-hFR-mGFP in all three mammalian cell lines (Fig. 2A–C).
3.2. KLK modulates the localization of various molecules along the
plasma membrane
We next tried to corroborate the link between the effects of KLK on
membrane targeting and protein or lipid glycosylation. For this, we
studied different classes of membrane constituents, among them
lipids, transmembrane proteins, inner- or outer leaﬂet integrated
proteins and peripheral membrane proteins, and followed the effects
of KLK on the localization of these molecules. The effect was observed
for i) the monosialylated lipid GM1, which was either labeled via the
ﬂuorescent ligand Cholera Toxin (CtxB) (Fig. 3A and B on T24 and
primary dendritic cells, respectively), or applied exogenously as
ﬂuorescent analogue (Fig. 3C); ii) the heavily sialylated single pass
transmembrane protein CD43-YFP [44] (Fig. 3D); iii) and CD63-GFP,an integrin complexing protein of the tetraspanin familywith putative
sialylation motifs [45] (Fig. 3E).
We also tested inner leaﬂet-associated proteins: i) Caveolin-1-GFP,
an integral scaffolding protein (Fig. 4A); ii) Lck-GFP (Fig. 4B) and Fyn-
YFP (Fig. 4C), two peripheral kinases involved in early T cell signaling
[46,47]; iii) Flotillin-1-GFP (Fig. 4D) and Flotillin-2-GFP (data not
shown) [48] and iv) Clathrin light chain-GFP [49] (Fig. 4E). These
proteins yielded no effect upon KLK treatment. We also observed no
effect for the following transmembrane proteins: i) the transferrin-
receptor CD71-GFP [50] (Fig. 4F); ii) the calcium channel-forming
polytopic transmembrane protein Orai1-GFP [51] (Fig. 4G); iii) the
integral membrane receptor CD147-YFP [52] (Fig. 4H); iv) the
polytopic transmembrane and preferentially caveolae-associated
receptor SR-BI-GFP [53] (Fig. 4I); v) CD3ζ-YFP [54] (Fig. 4J). Table 1
summarizes all molecules which have been tested in this study.
3.3. KLK interacts with the ectodomain of the affected protein
To further conﬁrm the relevance of the exoplasmic protein parts
for the observed redistribution, we studied the effect of KLK using
chimeric proteins [55]. The transmembrane region of CD45 fused to
Thy-1 showed no effect upon KLK treatment. However, when Thy-1
was replaced by the ectodomain of CD43, the KLK effect could be
reconstituted (Fig. 5). This result indicates that the extra-cellular
domain is responsible for the interaction with the peptide.
3.4. KLK-mediated re-localization requires modiﬁcation of the respective
protein with sialic acids
To directly prove the role of sialic acids we pretreated HeLa cells
expressing CD43-YFP with neuraminidase, which hydrolyses N-
acetyl-neuraminic acid residues from glycoproteins leading to the
cleavage of unbranched and branched sialic acids [56]. As already
shown in Fig. 3D KLK leads to the accumulation of the highly sialylated
protein CD43. We speculated that the cleavage of sialic acids from
CD43 would prohibit its accumulation in the plasma membrane upon
KLK treatment. Indeed, KLK did not change the localization of CD43-
YFP when the cells were pretreated by neuraminidase (Fig. 6). Similar
results were found for neuraminidase-treated cells expressing GPI-
hFR-mGFP (data not shown). We conclude that KLK interacts with
sialic acids resulting in the accumulation of the affected protein in the
plasma membrane. Due to the positive charge of KLK a direct binding
of the peptide to the negatively charged sialic acids seems likely.
Fig. 3. KLK modulates the localization of various molecules in the plasma membrane. Experiments were performed using TIRF microscopy in the absence or presence of 100 μM KLK
(5 min incubation time) on T24 or human immature dendritic cells labeled with CtxB-Alexa647 (A and B, respectively), T24 cells labeled with GM1-Bodipy (C), T24 cells expressing
CD43-YFP (D) or CD63-GFP (E). Scale bars 35 (A), 30 (B), 30 (C), 20 (D) and 30 (E) μm, respectively.
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In order to analyze the mobility of proteins that showed altered
localization upon KLK treatment, we carried out ﬂuorescence recoveryFig. 4. KLK does not affect the localization of speciﬁc plasma membrane proteins. Experime
(5 min incubation time) on T24 cells expressing Caveolin-1-GFP (A), Lck-GFP (B), Fyn-YFP (C
YFP (H), SR-BI-GFP (I) or CD3ζ-YFP (J). Scale bars 30 (A), 35 (B), 10 (C), 30 (D), 20 (E), 30after photobleaching (FRAP) experiments. We treated GPI-hFR-mGFP
expressing T24 cells with KLK and determined the mobile fraction after
30 s within deﬁned regions (Fig. 7). When selecting a region of KLK-
induced GPI-hFR-mGFP accumulation (marked with a red circle) wents were performed using TIRF microscopy in the absence or presence of 100 μM KLK
), Flotillin-1-GFP (D), Clathrin light chain-GFP (E), CD71-GFP (F), Orai1-GFP (G), CD147-
(F), 20 (G), 10 (H), 20 (I) and 15 (J) μm, respectively.
Fig. 5. KLK interacts with the ectodomain of the affected protein. HeLa cells expressing
CD43-YFP (A) or the fusion proteins CD43-CD45-YFP (B) or Thy1-CD45-YFP (C) were
incubated with 100 μMKLK for 5 min and analyzed using TIRF microscopy. Scales bars 20
(A), 15 (B) and 10 (C) μm, respectively.
Fig. 7. KLK leads to an immobilization of the accumulated proteins. T24 cells expressing GPI-
hFR-mGFP were treated with 100 μM KLK for 30 s and Fluorescence Recovery After
Photobleaching(FRAP)experimentswereperformed.Themobile fractionwithin twodeﬁned
regions (encircled region along the plasmamembrane or regionmarkedwith a square below
the cell) was recorded. Panel A indicates the ﬂuorescence image before, panel B and C the
ﬂuorescence image 100ms and 30 s after the bleach pulse, respectively. Scale bar 3 μm. The
mobile fraction within the two regions is plotted in panel D and was calculated from
measurements of ~15 individual cells. Error bars are based on the standard error of themean.
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lower compared to untreated cells (~80%)[42]. Regions in the bottom
part of the plasma membrane (marked with a green square) showed a
high mobile fraction similar to untreated cells, indicating that the
peptide was not able to diffuse into the gap between the cell and the
glass slide.
3.6. KLK induces invaginations of the plasma membrane
To visualize the effects of KLK on the plasma membrane at high
resolution, we used transmission electronmicroscopy on thin sections
(60–80 nm) cut in parallel to the plane of cell growth. When
comparing T24 cells incubated with 10 μM KLK to untreated cells,
two effects became apparent: Firstly, the plasma membrane showed
dramatic morphological changes including numerous membrane
invaginations (marked with white arrows), and additional circular
structures near the plasma membrane (marked with gray arrows)
(Fig. 8A–C). These structures were found to be enriched in GPI-hFR-
mGFP as shown by antibody-staining (Fig. 8D–E). Secondly, large
ﬁlamentous aggregates were formed in the extra-cellular space
(marked with black arrows in Fig. 8C).
While the invaginations most likely represent fusion or ﬁssion
intermediates, the interpretation of the circular structures is a priori not
clear: they may be interpreted as membrane proximal vesicles, or as the
consequence of invaginations cut in the ﬂattened peripheral cell
extension at a tangential cutting angle (see Supplementary Fig. 3). ToFig. 6. The KLK mediated re-localization of membrane-localized proteins is linked to a p
incubated with 1 U/ml neuraminidase to cleave sialic acids and treated afterwards with 100
bar 10 μm.decide which of these interpretations is correct, we performed ﬂuores-
cence quenching experiments. We used the membrane-impermeable
quencher Trypan Blue, which efﬁciently reduces the ﬂuorescence of
various ﬂuorophores. In the negative control, Trypan Blue did not
decrease the ﬂuorescence of the inner-leaﬂet peripheral membrane
protein Lact-C2-GFP (Fig. 8F–G). We then used KLK to accumulate GPI-
hFR-mGFP in the plasmamembrane of T24 cells. Addition of Trypan Blue
efﬁciently decreased the ﬂuorescence, in particular in regions with
accumulated GPI-hFR-mGFP (Fig. 8H–J), indicating that the ﬂuorescent
protein is accessible to the extracellular milieu. We conclude that the
accumulated proteins are located in plasmamembrane invaginations, but
not in membrane proximal vesicles.3.7. KLK ruptures the plasma membrane in the presence of positively
charged proteins bound to the inner leaﬂet
When testing the effect of KLK on the various proteins and lipids, we
made a surprising observation: KLK treatment of cells overexpressingost-translational modiﬁcation with sialic acids. HeLa cells expressing CD43-YFP were
μM KLK for 20 min. Pictures were taken 15 s, 5 min and 20 min after KLK addition. Scale
Fig. 8. KLK induces the formation of plasma membrane invaginations. Electron microscopic images of cross-sectioned plasma membrane in the periphery of T24 cells were recorded
in the absence (A) or after treatment with 10 μMKLK (B–C). Panels D and E show EM images of T24 cells expressing GPI-hFR-mGFP stained with a HRP-conjugated anti-GFP antibody
before and after KLK treatment, respectively (incubation time 5 min). White arrows mark membrane invaginations, gray arrows indicate additional circular structures near the
plasmamembrane and black arrowsmark large ﬁlamentous aggregates in the extra-cellular space. Additionally, themembrane impermeable quencher Trypan Blue (TB) was used to
determine the plasma membrane localization of GPI-anchored proteins after KLK treatment. T24 cells expressing GPI-hFR-mGFP (H) were incubated with 100 μM KLK for 5 min (I)
and treated with 0.2% TB (J). As a negative control T24 cells expressing the Phosphatidylserine (PS) binding probe Lact-C2-GFP were imaged by TIRF microscopy without (F) or with
0.2% Trypan Blue (G). Scale bars 20 (A), 10 (C), 1 (F), 0.5 (G and H) and 0.3 (I and J) μm, respectively.
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complete rupture of the cells. This result appeared interesting, knowing
that there is amanifold of positively chargedproteins suchas c-Src, Rac1
orK-Ras,whichare targeted to the inner leaﬂetof theplasmamembrane
via cationic motifs [57], and which can be expressed at high rates—
similar to our overexpressed constructs—under speciﬁc signaling
conditions [58,59]. To explore this phenomenon in more detail we
expressed GFP-labeled “charge sensors,”which combine a hydrophobicfarnesyl chain with an adjacent sequence of varying net positive charge
[60]. These probes bind to negatively charged lipid species at the inner
leaﬂet, particularly phosphatidylserine, phosphatidylinositol (3,4,5)-
trisphosphate (PIP3) and phosphatidylinositol (4,5)-bisphosphate
(PIP2) [61,62]. The sensor with the highest net charge, 8+-GFP, was
localizedpreferentially to the inner plasmamembrane leaﬂet.Within 3–
6 min upon KLK treatment we detected changes in its localization and
ﬁnally a complete breakup of the cells after 10–15 min (Fig. 9). This
Fig. 9. KLK ruptures the plasma membrane in the presence of positively charged proteins bound to the inner leaﬂet. T24 cells expressing a GFP-labeled probe that binds to negatively
charged lipids in the inner plasma membrane leaﬂet (8+-GFP) were analyzed by TIRF microscopy after incubation with 100 μM KLK. Images were taken before, and 3, 6 and 14 min
upon KLK addition. Additionally, an image was recorded 20 min after KLK treatment using confocal microscopy (E). Scale bars 10 (A) and 15 μm (E).
2588 J. Weghuber et al. / Biochimica et Biophysica Acta 1808 (2011) 2581–2590phenomenon was also observed for T24 cells expressing a PIP2/PIP3-
binding Pleckstrin-homology (PH)-YFP domain, and with a 4+-GFP
sensor (data not shown).
3.8. Hydrophobic regions are required to arrest sialylated proteins at the
plasma membrane
To obtain also mechanistic insights into the action of CAMPs on
host cell membranes we tested additional substances. LF11-322 is a
nonapeptide derived from Lactoferricin [63]; N-terminal acylation
with 6-methyloctanoyl to increase its membrane afﬁnity yielded the
variant 6-MO-LF11-322. Both CAMPs showed broad spectrum of
antimicrobial activity with MICs N1 μM (Zweytick et al., manuscript
submitted). Similar to the treatment with KLK, we found a clear
redistribution of CD43 in T24 cells upon incubation with 6-MO-LF11-
322 (Fig. 10A). Interestingly, incubation of the cells with the non-
acylated version LF11-322 showed no recognizable effect (Fig. 10B).
We also tested the CAMP NK14, an amphipathic peptide derived from
NK-2 [64,65], and its dimeric version (NK14-2). While NK14 did not
show any effect on CD43 localization, we found a clear redistribution
upon treatment with NK14-2 (Fig. 10C and D).
4. Discussion
We report here that application of the CAMPs KLK, 6-MO-LF11-322
and NK14-2 affects plasma membrane processes also on mammalian
host cells. In particular, we observed two effects:
i) Sialylated membrane proteins or lipids become immobilized and their
recycling is arrested. Sialylated proteins are involved in such
diverse processes as signaling [66], cellular adhesion and migra-
tion [67], receptor-mediated endocytosis and immune responseFig. 10. Effects of further antimicrobial peptides on the localization of sialylated membrane
10 min with 80 μM 6-MO-LF11-322 (A), 80 μM LF11-322 (B), 40 μM NK14 (C) and 20 μM N[68,69]. KLK may thus impose a broad spectrum of detrimental
nonlethal effects also to host cells. Interestingly, non-sialylated
proteins were not affected by these massive rearrangements.
At this stage we cannot rule out indirect effects; however, our
observations can be consistently summarized in a mechanistic
model of CAMP-induced immobilization. In contrast to the mutant
variant KPK, KLK has a strong tendency to multimerize [24].
Moreover, its high number of leucines generates a hydrophobic
domain, thereby yielding a great afﬁnity towards membranes; a
central proline reduces the membrane afﬁnity for KPK [24]. It thus
appears likely that KLK associates with the plasma membrane
resulting in a high surface density, so that negatively charged
protein modiﬁcations such as sialic acids can be efﬁciently bound
by the positive charges on the CAMP. In consequence, sialylated
molecules are multimerized and thereby immobilized in the
plasma membrane. The free energy of this process includes
therefore electrostatic and hydrophobic contributions. Since KPK
lacks themembrane afﬁnity, its density at the plasmamembrane is
substantially lower and not sufﬁcient to mediate the effect; in
other words, the hydrophobic term in the free energy is not
sufﬁcient for stabilizing the interaction. Consequentially, it was not
possible to compete for the KLK-induced crosslink by excess
concentrations of KPK.
Similar differential effects were observed for other CAMPs. We
found that only the acylated version of LF11-322—termed 6-MO-
LF11-322—mediated the arrest of CD43 at the plasma membrane.
Also for the amphipathic CAMPs NK14 and NK14-2 we observed
strong differences in their ability to arrest CD43: only the dimeric
peptide exhibiting a higher hydrophobic moment was able to
exert the effect, consistent with the higher membrane afﬁnity of
the dimeric construct. In conclusion, cooperation between hydro-
phobicity and electrostatic interactions may boost adverse effectsproteins. TIRF microscopy images of T24 cells expressing CD43-GFP were incubated for
K14-2 (D). Scale bars 25 (A), 20 (B), 25 (C) and 15 (D) μm.
2589J. Weghuber et al. / Biochimica et Biophysica Acta 1808 (2011) 2581–2590of CAMPs on eukaryotic host cell membranes. At this stage, we can
only speculate about the origin of the observed arrest of sialylated
proteins in the plasma membrane: invaginations may represent
ﬁssion or fusion intermediates, but may also be explained by
tension-induced formation of structures which are not related to
the cellular uptake machinery.
ii) The plasma membrane gets more susceptible to rupture. We ob-
served KLK to cause the total disintegration of the plasma
membrane when positively charged proteins were overexpressed.
In our study we used a protein motif derived from K-Ras [60],
overexpression of which is involved e.g. in cell proliferation [70].
Potential causes for the observed effect include the reduced
elasticity of the membrane due to the crowding of adsorbed
proteins on both leaﬂets, but also the shielding of phosphoinosi-
tides, thereby making them unavailable for signaling. Moreover,
lactoferricin derived peptides were shown to increase curvature
stress in lipid bilayer promoting the formation of highly curved
cubic structures [71]. Application of KLK as a CAMP may therefore
well disrupt cells containing high levels of cytosolic proteins with
polybasic motifs.
Taken together our study demonstrates potential far-reaching
effects of the application of CAMPs on the eukaryotic host cell and
provides insight into the consequences of peptide binding on the
plasma membrane localization and endocytosis of a subgroup of
membrane molecules. These ﬁndings are of great relevance for the
usage of cationic antimicrobial peptides per se: since many of them
have to be applied at high concentrations, it is likely that their usage
does not only affect the pathogen, but also the host cells. Whether
similar effects occur in eukaryotic cells upon exposition to natural
CAMPs may be an interesting topic for future studies.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamem.2011.06.007.
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